Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial electron transport chain ubiquinone pool, or Q-pool, is a collection of mobile, lipid-soluble ubiquinone molecules located within the inner mitochondrial membrane. It serves as a critical intermediary in the electron transport chain, shuttling electrons from Complex I and Complex II to Complex III to facilitate the generation of a proton gradient for ATP synthesis (StatPearls: Biochemistry, Electron Transport Chain). Beyond its role in bioenergetics, the pool acts as a potent antioxidant, neutralizing reactive oxygen species that can damage mitochondrial lipids and proteins (PubMed: PMID 17014895). Clinically, the ubiquinone pool is a target for supplementation in primary Coenzyme Q10 deficiencies and neurodegenerative diseases like Parkinson's, where analogs like Idebenone are used to bypass respiratory chain defects (NIH: GeneReviews). Additionally, the pool's interaction with Complex III is a pharmacological target for the antiprotozoal drug Atovaquone, which inhibits the ubiquinone-binding site to disrupt energy production in parasites (PubChem: Atovaquone). Therapeutic modulation of the pool aims to either restore electron flux in mitochondrial disorders or intentionally disrupt it to treat infections or certain cancers. Understanding the dynamics of this pool is essential for developing therapies that modulate mitochondrial health and cellular redox balance.
The ubiquinone pool facilitates the transfer of electrons from Complex I and II to Complex III within the mitochondrial inner membrane. Therapeutic agents either supplement the pool to restore respiratory chain function and provide antioxidant protection or competitively inhibit ubiquinone binding sites to disrupt mitochondrial bioenergetics in pathogens or cancer cells.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial electron transport chain ubiquinone pool (Q-pool).